11 research outputs found
PDB47 Short And Long-Term Cost-Effectiveness Of Switching Therapy From Biphasic Human Insulin 30 To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes
An analysis of the short- and long-term cost-effectiveness of starting biphasic insulin aspart 30 in insulin-naive people with poorly controlled type 2 diabetes
Short and Long-Term Cost-Effectiveness of Switching Therapy from NPH Insulin to Insulin Detemir in People with Type 2 Diabetes
Short and Long-Term Cost-Effectiveness of Switching Therapy from Insulin Glargine to Insulin Detemir in People with Type 2 Diabetes
Burden of allergic respiratory disease:a systematic review
Additional file 1: Table S1. Database search strategies; Figure S1. RQLQ domain scores by allergy phenotype. Studies are listed from the top as SAR, Mixed, and PAR; Figure S2 SF-36 domain scores by allergy phenotype. Studies are listed from the top as SAR, Mixed, and PAR
Short And Long-Term Cost-Effectiveness Of Starting Insulin Detemir In Insulin-NaĂŻve People With Type-2 Diabetes
Short And Long-Term Cost-Effectiveness Of Switching Therapy From Biphasic Human Insulin 30 To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes
MOESM1 of Burden of allergic respiratory disease: a systematic review
Additional file 1: Table S1. Database search strategies; Figure S1. RQLQ domain scores by allergy phenotype. Studies are listed from the top as SAR, Mixed, and PAR; Figure S2 SF-36 domain scores by allergy phenotype. Studies are listed from the top as SAR, Mixed, and PAR
Burden of allergic respiratory disease: a systematic review
Abstract This meta-analysis compared the health-related quality of life (HRQL) of patients with allergic rhinitis (AR) and/or allergic asthma (AA) caused by perennial house dust mite (HDM) versus AR and/or AA caused by seasonal pollen allergy. Following a systematic search, the identified studies used the disease-specific rhinitis quality of life questionnaire or generic instruments (SF-36 and SF-12). Summary estimates obtained by meta-analysis showed that HRQL in patients with perennial HDM allergy was significantly worse than that of patients with seasonal pollen allergy, when measured by both disease-specific and generic HRQL instruments, and was reflected by an impact on both physical and mental health. A systematic review of cost data on AR and AA in selected European countries demonstrated that the majority of the economic burden was indirectly caused by high levels of absenteeism and presenteeism; there was little or no evidence of increasing or decreasing cost trends. Increased awareness of the detrimental effects of AR and/or AA on patientsâ HRQL and its considerable cost burden might encourage early diagnosis and treatment, in order to minimize the disease burden and ensure beneficial and cost-effective outcomes